CLIA Complexity: WAIVED INTENDED USE SUMMARY AND EXPLANATION

Similar documents
CLIA Complexity: Waived

CLIA Complexity: WAIVED

PROCEDURE MANUAL. Prepared By Date Adopted Supersedes Procedure # Review Date Revision Date Signature

PROCEDURE. Sekisui Diagnostics OSOM ifob Rapid Test. Title: Procedure #: Institution: Prepared by: Date: Title: Accepted by: Date adopted: Title:

ifob Test Rev. P5576-A, 04/16 5. Read the result in 5-10 minutes. RESULTS AFTER 10 MINUTES. Important: DO NOT READ

ifob Test Rev. P /15 6. Read the result in 5-10 minutes. RESULTS AFTER 10 MINUTES. Important: DO NOT READ

PROCEDURE MANUAL. Prepared By Date Adopted Supersedes Procedure # Review Date Revision Date Signature

Rapid-VIDITEST FOB Blister

REFERENCES HemaPrompt FG Product Information. June, Aerscher Diagnostics, Chestertown, MD.

Discussion. Points: 20. Objectives:

Rotavirus Test Kit. Instructions For Use. Format: Cassette Specimen: Fecal Extract Catalog Number: VEL-001-ROTA

CDIA TM Rubella IgG/IgM Rapid Test Kit

JOHN H. STROGER HOSPITAL OF COOK COUNTY ANNUAL TRAINING HEMOCCULT

Helicobacter pylori Antigen Test

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation

Rapid-VIDITEST. FOB+Tf. One step Fecal Occult Blood Card Test. Instruction manual

Rapid-VIDITEST Calprotectin

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line)

INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY

Written By: Joann O Connor Date: 01/27/2017 Effective Date: 02/22/2017 1

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents

PROCEDURE MANUAL. Procedure: CLIA Complexity: Waived for Whole Blood, Moderate for Serum, Plasma. Prepared By Date Adopted Supersedes Procedure #

QUICK REFERENCE INSTRUCTIONS

Chlamydia Rapid Screen Test (RAP-2858) RUO in the USA. Revised 28 Jul 2006

FECAL OCCULT BLOOD TEST (FOBT) Common Guaiac versus Immunochemical Test

FOR INFORMATIONAL USE ONLY

Human Influenza A (Swine Flu) Rapid test

Hepatitis C Virus (HCV) Antibody Test

Chlamydia trachomatis (CHLa)Test Kit

IVD Revised 22 July, 2008

Fecal H. pylori Antigen Rapid Test (Strip)

Rapid-VIDITEST Swine Flu

CLIA Complexity: WAIVED

Treponema Pallidum (TP) Antibody Test

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

HARBOR-UCLA MEDICAL CENTER Torrance, California DEPARTMENT OF EMERGENCY MEDICINE POLICY AND PROCEDURE MANUAL

NEGATIVE POSITIVE. Rev , 06/11. 5 min. Mono Test. For fi ngertip. blood: 1 DROP 1 DROP For serum, whole blood. plasma or. samples.

HAV IgM Rapid Test(Cassette)

Contents. Approved by: Kent Lewandrowski, M.D. 6/1/2005 Written/Updated by: Gino Pagnani Date: 4/3/09

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister

Rapid-VIDITEST. Astrovirus Card

Strep-a-Test Twister Test

Rapid-VIDITEST. Helicobacter pylori. One step Helicobacter pylori Blister test. Instruction manual

QUICK REFERENCE INSTRUCTIONS. THYROCHEK TSH Cassette

QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only

QUICK REFERENCE INSTRUCTIONS For use with Sofia only.

Influenza A & B Screening

Dengue IgG/IgM/NS1 Combo Rapid Test Device

Mono Test 1 DROP 1 DROP. For fingertip blood: For serum, plasma or whole blood samples in tubes: Rev , 05/09

Malaria Pf/pan antigen Rapid Test

IBD EZ VUE I. PRINCIPLE

INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY

Rapid-VIDITEST. Strep A Blister. One step Strep A Blister for the detection of Group A Streptococcal antigen from throat swabs or culture.

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

H. Pylori Whole Blood Rapid Test

Safety Data Sheet. Section 1: Identification

Rapid-VIDITEST. Rota-Adeno Blister. One Step Rotavirus and Adenovirus Antigen Blister test. Instruction manual

Rapid-VIDITEST. Calprotectin-Lactoferrin

HAV IgG/IgM Rapid Test

Version No.: 5.0 TITLE: SDS FOR FECAL OCCULT BLOOD TEST KIT T1-CK SERIES Page 1 of 5

biorapid FOBT 20 Test cod

See external label. 2 C-30 C for test card and Sample tube Cat.# OneStep Rotavirus Antigen RapiCard InstaTest.

Summary of Significant Changes at this Revision. Items Required. Printed copies are uncontrolled unless there is an allocated Copy Number on page 1

NCCLS. Accutest H. pylori WB Test. (Catalog. No. ID-92A225) For Professional and In Vitro Diagnostic Use Only

FOR USE WITH SOFIA. For in vitro diagnostic use.

Rapid-VIDITEST. Strep A Card. One step Strep A Card for the detection of Group A Streptococcal antigen from throat swabs or culture.

Rapid-VIDITEST. Influenza A+B

Urinalysis and Body Fluids CRg. Feces. Feces. Unit 5. 5 Feces & miscellaneous handouts draft

Product Training & Certification

Infectious Mononucleosis IM Cassette Test RAPU04A830

Rapid-VIDITEST Enterovirus

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

A rapid test for the qualitative detection of Malaria pf and pv antigen in human blood sample

Rapid-VIDITEST Shigella dysenteriae

PreventID TSH. Additional information Manual Medical information

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.

Product Training & Certification

MALARIA P. FALCIPARUM / P. VIVAX

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HIV 1/2 Rapid Antibody Test WHO reference number: PQDx

TB LAM Ag Lateral Flow Assay Standard Operating Procedure

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HIV 1/2 Rapid Antibody Test WHO reference number: PQDx

Estrone EIA kit. For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media. Cat. No.

H.Pylori IgG

H.Pylori IgG Cat # 1503Z

HBeAg and HBeAg Ab ELISA Kit

Toxoplasma gondii IgM ELISA Kit

H. pylori IgM CLIA kit

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

OratectPlus Oral Fluid Drug and Alcohol Screen Device Training and Certification Program

SAMPLE PROCEDURE , 07/11

E. Histolytica IgG (Amebiasis)

Design Verification Function... 2 Analytical sensitivity... 2 Specificity, cross-reactivity and interferences... 3

25 OH Vitamin D Rapid test

Hepatitis A virus IgM ELISA Kit

Cotinine (Mouse/Rat) ELISA Kit

H.pylori IgA Cat #

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

Rubella Latex Agglutination Test

Ralstonia solanacearum PathoScreen Kit DAS ELISA, peroxidase label Catalog number: PSP 33900

Transcription:

CLIA Complexity: WAIVED INTENDED USE The QuickVue ifob (immunochemical Fecal Occult Blood) test is an immunochemical device intended for the qualitative detection of fecal occult blood by laboratories or physicians offices. It is useful in determining gastrointestinal (GI) bleeding found in a number of gastrointestinal disorders, such as: diverticulitis, colitis, polyps, and colorectal cancer. This test is recommended for use in: (1) routine physical examinations or when hospital patients are first admitted, (2) hospital monitoring for GI bleeding in patients, and (3) screening for colorectal cancer or gastrointestinal bleeding from any source. SUMMARY AND EXPLANATION The American Cancer Society and Centers for Disease Control recommend a fecal occult blood test annually after age 50 to aid in the early detection of colorectal cancer. 1 The Guaiac test is widely available but lacks high accuracy. Guaiac is a naturally occurring phenolic compound that can be oxidized to quinone by hydrogen peroxidases with a detectable color change. The sensitivity and specificity of Guaiac tests are much lower than those of Immunochemical assays. The low accuracy of the Guaiac dye method is related to dietary peroxidases, including hemoglobin and myoglobin from meat and uncooked fruits and vegetables. Additionally, iron intake may cause false positive results with Guaiac tests. 2 The is much more sensitive and has been designed to be more specific in detecting low levels of human fecal occult blood. It is highly accurate compared to the Guaiac method. The results of immunochemical FOB rapid tests are not affected by dietary peroxidases, animal blood or ascorbic acid. A Japanese study demonstrated using immunochemical FOB tests reduced colorectal cancer-related mortality by 60%. 3 Page 1 of 11

PRINCIPLE OF THE TEST The is a one-step lateral flow chromatographic immunoassay. The test strip consists of: (1) a burgundy colored conjugate pad containing mouse anti-hhb antibodies conjugated with colloidal gold and (2) a nitrocellulose membrane strip containing a Test line (T-line) and a Control line (C-line). The T-line is coated with anti-hhb antibodies, and the C-line is coated with goat anti-mouse IgG antibodies. When the correct volume of test specimen is dispensed into the sample well of the device, the test specimen migrates across the test strip. If the concentration of hhb in the specimen is at or above 50 ng hhb/ml or 50µg hhb/g feces, the T-line appears as a visible burgundy line. If the concentration of hhb in the specimen is below the detectable level, no T-line develops. The C-line is coated with goat anti-mouse antibody, which binds to the conjugated monoclonal antibody, regardless of the presence of hhb in the specimen. REAGENTS AND MATERIALS SUPPLIED Individually Wrapped Test Cassettes (50) Specimen Collection Tubes (50), each containing 2 ml FOB buffer (1x PBS with 0.02% sodium azide) Package Insert (1) MATERIALS REQUIRED BUT NOT PROVIDED Timing Device. WARNINGS AND PRECAUTIONS The is for in vitro diagnostic use. Do not use the kit contents beyond the expiration date printed on the outside of the box. Dispose of containers and used contents in accordance with Federal, State and Local requirements. Use of Nitrile or Latex gloves is recommended when handling potentially infectious fecal specimens. 4,5 Follow proper hand washing hygiene after handling potentially infectious fecal specimens. The Test Cassette must remain sealed in the foil pouch until just prior to use. Treat all specimens and used assay materials as if they are infectious. 4,5 To obtain accurate results, you must follow the Package Insert instructions. Page 2 of 11

KIT STORAGE AND STABILITY Store the kit at room temperature 59 86 F (15 30 C), out of direct sunlight. Do not expose kit components to temperatures over 86 F (30 C). Kit contents are stable until the expiration date printed on the outer box. Do not freeze. SPECIMEN COLLECTION AND STORAGE The specimen used in this assay is feces. Collect specimen in bedpan, a clean cup, or like container. NOTE: Do not collect specimen if bleeding hemorrhoids, or if menstrual, constipation, or urinary bleeding are present. Do not allow specimen to come in contact with toilet water. 1. Enter the Patient Identification information on the Collection Tube label. 2. Unscrew the Sampler from the Collection Tube. Unscrew Sampler Sampler Assembled Collection Tube Collection Tube with Bu er 3. Randomly pierce the specimen with the grooved end of the Sampler in at least five (5) different sites. Fecal Specimen Collection Grooves Specimen sample inside grooves Page 3 of 11

4. Insert the Sampler into the Collection Tube and firmly tighten it. 5. Shake the tube to mix the specimen and the FOB buffer. Tighten Shake well NOTE: Specimens collected may be stored up to eight (8) days at ambient temperatures below 95 F (35 C), six (6) months at 36 46 F (2 8 C) or two (2) years at -4 F ( -20 C). QUALITY CONTROL Built-in Control Features The contains a built-in control feature, the Control line (C-line). The presence of this burgundy C-line indicates that an adequate specimen volume was used and that the reagents migrated properly. If a C-line does not form, the test is considered invalid. In this case, review the entire procedure and repeat the test with a new device. External Quality Control Good laboratory practice recommends the use of external quality controls to assure the functionality of reagents and proper performance of the test procedure. For this purpose, we recommend using the QuickVue ifob Control Set (Catalog Number: 20197). External Controls should be tested following the Test Procedure section. If the controls do not perform as expected, repeat the test or contact Quidel Technical Support before testing patient specimens. Page 4 of 11

ifob FOR INFORMATIONAL USE ONLY FOR INFORMATIONAL USE ONLY TEST PROCEDURE All Test Cassettes and clinical specimens must be at room temperature before beginning the test. Remove the Test Cassette from the pouch and place it on a clean, flat, dry, level surface. C T Put on gloves before performing the following steps. Shake the Collection Tube to mix the specimen and the FOB buffer. Hold the Collection Tube upright, as shown. Remove the light blue screw cap by turning. Screw Cap Tip Fully cover tip with absorbent material to avoid potential contact with specimen solution. Page 5 of 11

QUICKLY snap off tip. DO NOT TWIST. SNAP AWAY Holding the Collection Tube vertically, dispense six (6) drops of specimen solution from the Collection Tube into the center of the Sample Well. Squeeze Here Place six (6) drops in center of well x6 C T ifob READ RESULTS AT 5 10 MINUTES. Some positive results may be seen earlier. IMPORTANT: Do not read the test results after ten (10) minutes. Page 6 of 11

INTERPRETATION OF RESULTS Refer to the Procedure Card for visual color interpretation of the Test and Control Lines. Both the T-line and the C-line present as the same burgundy color. Positive Result: If both a C-line and a T-line are present, the result is positive. A positive result indicates the level of hhb in the specimen is at or above the detection level. Negative Result: If only the C-line develops in the control region of the test strip, the result is negative. Invalid Result: If no C-line appears within 5 minutes, the result is invalid and the assay should be repeated with a new device. NOTE: The test line may or may not be present. However, the absence of a control line indicates an invalid test. Page 7 of 11

LIMITATIONS The is intended only for the detection of human hemoglobin in feces. Results cannot be considered conclusive evidence of the presence or absence of gastrointestinal bleeding or pathology. A positive result should be followed up with additional diagnostic procedures to determine the exact cause and source of the occult blood in the feces. A negative result can be obtained even when a gastrointestinal disorder is present. For example, some polyps and colorectal cancers may bleed intermittently or not at all during certain stages of the disease. False negative results may occur when occult blood is not uniformly distributed throughout the bowel movement and the formation of a fecal specimen. Repeat testing is recommended if a pathological condition is suspected. Patients with the following conditions should not be considered for testing, as these conditions may interfere with test results: Menstrual bleeding Bleeding hemorrhoids Constipation bleeding Urinary bleeding However, these patients may be considered for testing after such bleeding ceases. Alcohol and certain medications such as aspirin, indomethacin, reserpine, phenylbutazone, corticosteroids and nonsteroidal anti-inflammatory drugs may cause gastrointestinal irritation and subsequent bleeding in some patients. EXPECTED RESULTS The will show positive results if there is a detectable amount of human hemoglobin in the specimen. The detection level is 50 ng hhb/ml buffer or 50 µg hhb/g feces. Page 8 of 11

PERFORMANCE CHARACTERISTICS Sensitivity The sensitivity of the test is 50 ng hhb/ml buffer or 50 µg hhb/g feces. Accuracy Reference Laboratory and Physicians' Office Laboratory (POL) Studies One hundred (100) hhb-free feces extraction specimens collected in-house were divided into 5 groups of 20 each. The five groups of extraction specimens were spiked with hhb for five different concentrations, respectively: 0, 37.5 ng hhb/ml, 50 ng hhb/ml, 62.5 ng hhb/ml, and 2000 ng hhb/ml. Those specimens were blind labeled and tested with the at three (3) Physicians' Office Laboratories and a Reference Laboratory. The results obtained from the three POL sites by persons with diverse educational background and work experience were 97.7% accurate, and the results from the Reference Laboratory were 99% accurate. Thus, overall the accuracy of the QuickVue ifob test is 98%. Specificity The is specific to human hemoglobin. The following substances, when spiked in both positive and negative specimens, did not interfere with the test results. Substance Concentration (µg/ml) Beef Hemoglobin 2,000 Chicken Hemoglobin 500 Fish Hemoglobin (meat extract) 100 Horse Hemoglobin 500 Goat Hemoglobin 500 Pig Hemoglobin 500 Rabbit Hemoglobin 60 Sheep Hemoglobin (meat extract) 100 Horseradish Peroxidase 20,000 Red radish Raw turnip Cauliflower Broccoli Parsnip Cantaloupe Vitamin C (ascorbic acid) Dietary supplement Iron Dietary supplement Page 9 of 11

ASSISTANCE If you have any questions regarding the use of this product, please call Quidel s Technical Support number, (800) 874-1517 (toll-free in the U.S.A.) or (858) 552-1100, Monday through Friday, between 7:00 a.m. and 5:00 p.m. Pacific Time, U.S.A. If outside the United States, contact your local distributor or technicalsupport@quidel.com. REFERENCES 1. American Cancer Society, Inc. Cancer Reference Information: Can Colon and Rectum Cancer Be Found Early? [Online] Available: http://www.cancer.org. 2. Allison JB, Takawa IS, Ransom LJ, Adrian AL. A comparison of fecal occult blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155 159. 3. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing (Review). Jpn J Cancer Res 1996; 87:1011 1024. 4. Recommendations for the Prevention of HIV Transmission in Health Care Settings, Morbidity and Mortality Weekly Report, Centers for Disease Control, August, 1987. 5. Biosafety in Microbiological and Biomedical Laboratories, 4th Edition. U.S. Department of Health and Human Services, CDC, NIH, Washington, DC (1999). Page 10 of 11

20201 50 test kit Quidel Corporation Worldwide Headquarters 10165 Mckellar Court San Diego, CA 92121 USA www.quidel.com 1129902 (08/10) Manufacturer Temperature Limit For in vitro diagnostic use Page 11 of 11